Adem Küçük
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Adem Küçük has a total of 185 co-authors. Here are the top co-authors by number of shared publications:
- Erkan Cure
İstinye University
7 shared publications Yasemin Mirza
Department of Physiotherapy and Rehabilitation, Necmettin Erbakan University Faculty of Health Sciences, Konya, Türkiye
7 shared publications- Ahmet Omma
Department of Internal Medicine, Division of Rheumatology, Ankara City Hospital, University of Health Sciences, 06800 Ankara, Turkey
4 shared publications - Bünyamin Kısacık
Department of Rheumatology, Sanko University Medical Faculty Hospital, 16049 Gaziantep, Turkey
4 shared publications - Medine Cumhur Cure
Department of Biochemistry, Private Tanfer Hospital, Istanbul, Turkey
4 shared publications - Gezmiş Kimyon
Department of Rheumatology, Mustafa Kemal University, 31040 Hatay, Turkey
3 shared publications
Latest Publications
- 20 August 2026
- Published by Taylor & Francis in Scandinavian Journal of Rheumatology
- Vol. 55 (6) , 447-457
Factors associated with shorter time to death and causes of mortality among deceased patients with systemic sclerosis: a multicentre retrospective study
Systemic sclerosis (SSc), also known as scleroderma, is a rare and complex autoimmune connective tissue disease. It is characterized by progressive fibrosis, vascular abnormalities, and severe comp...
- 20 August 2026
- Published by Taylor & Francis in Scandinavian Journal of Rheumatology
- Vol. 55 (6) , 447-457
Factors associated with shorter time to death and causes of mortality among deceased patients with systemic sclerosis: a multicentre retrospective study
Systemic sclerosis (SSc), also known as scleroderma, is a rare and complex autoimmune connective tissue disease. It is characterized by progressive fibrosis, vascular abnormalities, and severe comp...
- Open Access
- 29 July 2026
- Published by Caleo in Rheumatology Quarterly
- Vol. 4 (3) , 218-226
Pelvic Floor and Sexual Dysfunction in Women with Fibromyalgia Syndrome: Clinical Associations and Pelvic Floor Health Knowledge
Objective: This study aimed to determine the severity of pelvic floor dysfunction (PFD) in women with fibromyalgia syndrome (FMS) using patient-reported outcome measures and to examine its relationship with sexual dysfunction, pelvic floor health knowledge, disease activity, and fatigue. Methods: A total of 51 women diagnosed with FMS (mean age: 46.14 ± 8.06 years) who attended a rheumatology outpatient clinic and met the eligibility criteria were enrolled. Sexual function was assessed using the Female Sexual Function Index (FSFI). Pelvic floor symptoms and their impact were evaluated with the Pelvic Floor Distress Inventory-20 (PFDI-20) and the Pelvic Floor Impact Questionnaire-7 (PFIQ-7), while knowledge and awareness were measured using the Pelvic Floor Health Knowledge Test (PFHKT). Disease activity and fatigue were assessed via the Fibromyalgia Impact Questionnaire (FIQ) and the Fatigue Severity Scale (FSS), respectively. Associations were examined using Spearman correlation analysis. Results: Weak correlations were observed between PFDI-20 scores and FIQ, FSS, and several FSFI domains (r=0.23-0.34, P < .05). Pelvic floor–related symptoms, including bladder, bowel, and pelvic organ complaints, were negatively associated with sexual function domains. As expected, strong positive correlations were observed between the total and subscale scores of the PFDI-20 and PFIQ-7 (r=0.67-0.93, P < .001). Conclusion: Pelvic floor dysfunction may be associated with impaired sexual function and greater disease burden in women with FMS. Incorporating pelvic floor assessment into clinical evaluation and considering multidisciplinary management approaches may be beneficial. However, these findings should be interpreted with caution due to the relatively weak correlations observed and the absence of a control group.
- 29 July 2026
- Published by Caleo in Rheumatology Quarterly
- Vol. 4 (3) , 218-226
Open AccessPelvic Floor and Sexual Dysfunction in Women with Fibromyalgia Syndrome: Clinical Associations and Pelvic Floor Health Knowledge
Objective: This study aimed to determine the severity of pelvic floor dysfunction (PFD) in women with fibromyalgia syndrome (FMS) using patient-reported outcome measures and to examine its relationship with sexual dysfunction, pelvic floor health knowledge, disease activity, and fatigue. Methods: A total of 51 women diagnosed with FMS (mean age: 46.14 ± 8.06 years) who attended a rheumatology outpatient clinic and met the eligibility criteria were enrolled. Sexual function was assessed using the Female Sexual Function Index (FSFI). Pelvic floor symptoms and their impact were evaluated with the Pelvic Floor Distress Inventory-20 (PFDI-20) and the Pelvic Floor Impact Questionnaire-7 (PFIQ-7), while knowledge and awareness were measured using the Pelvic Floor Health Knowledge Test (PFHKT). Disease activity and fatigue were assessed via the Fibromyalgia Impact Questionnaire (FIQ) and the Fatigue Severity Scale (FSS), respectively. Associations were examined using Spearman correlation analysis. Results: Weak correlations were observed between PFDI-20 scores and FIQ, FSS, and several FSFI domains (r=0.23-0.34, P < .05). Pelvic floor–related symptoms, including bladder, bowel, and pelvic organ complaints, were negatively associated with sexual function domains. As expected, strong positive correlations were observed between the total and subscale scores of the PFDI-20 and PFIQ-7 (r=0.67-0.93, P < .001). Conclusion: Pelvic floor dysfunction may be associated with impaired sexual function and greater disease burden in women with FMS. Incorporating pelvic floor assessment into clinical evaluation and considering multidisciplinary management approaches may be beneficial. However, these findings should be interpreted with caution due to the relatively weak correlations observed and the absence of a control group.
- 30 June 2026
- Published by Balikesir University in BALIKESIR HEALTH SCIENCES JOURNAL
- Vol. 15 (2) , 293-301
Static Foot Posture and its Relationship with Clinical Variables in Axial Spondyloarthritis Patients Participating in Leisure-time Activities
Objective: This study aimed to assess static foot posture in patients with axial spondyloarthritis (axSpA) and to examine its association with clinical and postural variables. Materials and methods: Forty-one patients with axSpA and 41 age- and sex-matched healthy controls were included. Static foot posture was evaluated using a podoscope combined with three-dimensional scanning and computerized analysis software. Spinal posture was measured with a digital inclinometer, and spinal mobility was assessed using the Bath Ankylosing Spondylitis Metrology Index (BASMI). Disease activity, functional status, and quality of life were evaluated using the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI), and Ankylosing Spondylitis Quality of Life questionnaire (ASQoL), respectively. Results: No significant difference was found between groups regarding the Arch Index (AI) (p = 0.143). However, non-neutral foot postures, including pronated and supinated patterns, were significantly more frequent in the axSpA group (p < 0.001). Lumbar lordosis differed significantly between patients and healthy controls (p < 0.001). Subgroup analysis demonstrated that pain severity was significantly higher in patients with pes planus and pes cavus compared with those with neutral foot posture (p = 0.035 and p = 0.045, respectively). Additionally, AI was significantly associated with pain severity at rest and during activity. Conclusion: Altered static foot posture is common in axSpA. Foot involvement and its functional implications should be evaluated as part of routine clinical assessment, irrespective of disease activity.
- 30 June 2026
- Published by Balikesir University in BALIKESIR HEALTH SCIENCES JOURNAL
- Vol. 15 (2) , 293-301
Static Foot Posture and its Relationship with Clinical Variables in Axial Spondyloarthritis Patients Participating in Leisure-time Activities
Objective: This study aimed to assess static foot posture in patients with axial spondyloarthritis (axSpA) and to examine its association with clinical and postural variables. Materials and methods: Forty-one patients with axSpA and 41 age- and sex-matched healthy controls were included. Static foot posture was evaluated using a podoscope combined with three-dimensional scanning and computerized analysis software. Spinal posture was measured with a digital inclinometer, and spinal mobility was assessed using the Bath Ankylosing Spondylitis Metrology Index (BASMI). Disease activity, functional status, and quality of life were evaluated using the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI), and Ankylosing Spondylitis Quality of Life questionnaire (ASQoL), respectively. Results: No significant difference was found between groups regarding the Arch Index (AI) (p = 0.143). However, non-neutral foot postures, including pronated and supinated patterns, were significantly more frequent in the axSpA group (p < 0.001). Lumbar lordosis differed significantly between patients and healthy controls (p < 0.001). Subgroup analysis demonstrated that pain severity was significantly higher in patients with pes planus and pes cavus compared with those with neutral foot posture (p = 0.035 and p = 0.045, respectively). Additionally, AI was significantly associated with pain severity at rest and during activity. Conclusion: Altered static foot posture is common in axSpA. Foot involvement and its functional implications should be evaluated as part of routine clinical assessment, irrespective of disease activity.
- 6 April 2026
- Published by Taylor & Francis in Disability and Rehabilitation
- Vol. 48 (21) , 1-12
Turkish translation, cultural adaptation, and psychometric evaluation of the Qualisex questionnaire in patients with axial spondyloarthritis
To translate and culturally validate the Qualisex questionnaire into Turkish and investigate its psychometric properties, including internal consistency, test-retest reliability, reproducibility, convergent and structural validity, and floor and ceiling effects in patients with axial spondyloarthritis (axSpA). The English version of the Qualisex was translated and culturally adapted into Turkish in accordance with international guidelines. Psychometric properties structural validity (factor analysis) internal consistency (Cronbach's alpha), test-retest reliability (intraclass correlation coefficient [ICC]), measurement error (standard error of the measurement [SEM], minimal detectable difference [MDD]), and convergent validity were studied. Floor and ceiling effects were also analyzed. Eighty-one patients with axSpA were included. We found a very good internal consistency (Cronbach's α of 0.91) and excellent test-retest reliability (ICC of 0.99) of the Turkish Qualisex. The SEM demonstrated a range between 0.15 and 0.50, and the MDD was observed to vary from 0.41 to 1.44. The total Qualisex score significantly correlated with the Bath Ankylosing Spondylitis Metrology Index (BASMI), Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI), and Ankylosing Spondylitis Quality of Life (ASQoL), disease duration, and pain severity. One factor was identified within the Qualisex. Our data suggest that the Turkish Qualisex is reliable and valid outcome measure for assessing quality of sexual life in patients with axSpA.
- 6 April 2026
- Published by Taylor & Francis in Disability and Rehabilitation
- Vol. 48 (21) , 1-12
Turkish translation, cultural adaptation, and psychometric evaluation of the Qualisex questionnaire in patients with axial spondyloarthritis
To translate and culturally validate the Qualisex questionnaire into Turkish and investigate its psychometric properties, including internal consistency, test-retest reliability, reproducibility, convergent and structural validity, and floor and ceiling effects in patients with axial spondyloarthritis (axSpA). The English version of the Qualisex was translated and culturally adapted into Turkish in accordance with international guidelines. Psychometric properties structural validity (factor analysis) internal consistency (Cronbach's alpha), test-retest reliability (intraclass correlation coefficient [ICC]), measurement error (standard error of the measurement [SEM], minimal detectable difference [MDD]), and convergent validity were studied. Floor and ceiling effects were also analyzed. Eighty-one patients with axSpA were included. We found a very good internal consistency (Cronbach's α of 0.91) and excellent test-retest reliability (ICC of 0.99) of the Turkish Qualisex. The SEM demonstrated a range between 0.15 and 0.50, and the MDD was observed to vary from 0.41 to 1.44. The total Qualisex score significantly correlated with the Bath Ankylosing Spondylitis Metrology Index (BASMI), Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI), and Ankylosing Spondylitis Quality of Life (ASQoL), disease duration, and pain severity. One factor was identified within the Qualisex. Our data suggest that the Turkish Qualisex is reliable and valid outcome measure for assessing quality of sexual life in patients with axSpA.
- 6 October 2025
- Published by Springer Nature in Clinical Rheumatology
- Vol. 44 (11) , 4689-4701
The efficacy of a telerehabilitation-based clinical Pilates program on lumbopelvic muscle morphology and strength in female patients with fibromyalgia syndrome: a randomized controlled trial
Introduction The current study aims to assess the effects of a tele-rehabilitation-based clinical Pilates exercise program on morphological structure, endurance, central sensitization, pain, fatigue, anxiety, and depression in Fibromyalgia syndrome (FMS) patients. Method Thirty women with FMS were randomized into two groups: the telerehabilitation group (TG) or the control group (CG). An online clinical Pilates-based exercise program targeting stability and strength that was conducted for 8 weeks with 2 sessions per week was developed for TG. The same exercise programs for the CG were provided in printed brochures. Lumbopelvic muscle thickness, core endurance tests, disease activity, fatigue, central sensitization, pain, anxiety, and depression were evaluated in patients at the beginning and end of the study. Results Decrease in lumbopelvic muscle thickness and core endurance strength in FMS patients compared to healthy individuals (p < 0.017). There was a significant effect of group × time interaction (F = 4.900, p = 0.035; F = 5.063, p = 0.032) for external oblique (right and left, respectively), fatigue (F = 15.489, p < 0.001), central sensitization (F = 17.518, p < 0.001), anxiety (F = 8.672, p = 0.006) in favor of the TG. Significant time effects were observed across all examined outcomes, covering lumbopelvic muscle thickness, fatigue, central sensitization, anxiety, depression, and core endurance strength (p < 0.05). Following the 8-week intervention, both groups exhibited significant within-group decreases in disease activity and pain. However, the TG demonstrated significantly greater improvements in disease activity and pain compared with the CG (p < 0.05). Conclusion Telerehabilitation-based treatment programs are effective in increasing lumbopelvic muscle thickness and core muscle endurance. Accordingly, we recommend the widespread use of this innovative treatment approach in FMS. Keypoints • FMS patients indicated lower core endurance strengths compared to healthy groups • TG showed greater improvements in muscle thickness and core endurance strength • Telerehabilitation is feasible and effective for managing the complexities of FMS • The telerehabilitation program was superior and more effective than home exercises
- 6 October 2025
- Published by Springer Nature in Clinical Rheumatology
- Vol. 44 (11) , 4689-4701
The efficacy of a telerehabilitation-based clinical Pilates program on lumbopelvic muscle morphology and strength in female patients with fibromyalgia syndrome: a randomized controlled trial
Introduction The current study aims to assess the effects of a tele-rehabilitation-based clinical Pilates exercise program on morphological structure, endurance, central sensitization, pain, fatigue, anxiety, and depression in Fibromyalgia syndrome (FMS) patients. Method Thirty women with FMS were randomized into two groups: the telerehabilitation group (TG) or the control group (CG). An online clinical Pilates-based exercise program targeting stability and strength that was conducted for 8 weeks with 2 sessions per week was developed for TG. The same exercise programs for the CG were provided in printed brochures. Lumbopelvic muscle thickness, core endurance tests, disease activity, fatigue, central sensitization, pain, anxiety, and depression were evaluated in patients at the beginning and end of the study. Results Decrease in lumbopelvic muscle thickness and core endurance strength in FMS patients compared to healthy individuals (p < 0.017). There was a significant effect of group × time interaction (F = 4.900, p = 0.035; F = 5.063, p = 0.032) for external oblique (right and left, respectively), fatigue (F = 15.489, p < 0.001), central sensitization (F = 17.518, p < 0.001), anxiety (F = 8.672, p = 0.006) in favor of the TG. Significant time effects were observed across all examined outcomes, covering lumbopelvic muscle thickness, fatigue, central sensitization, anxiety, depression, and core endurance strength (p < 0.05). Following the 8-week intervention, both groups exhibited significant within-group decreases in disease activity and pain. However, the TG demonstrated significantly greater improvements in disease activity and pain compared with the CG (p < 0.05). Conclusion Telerehabilitation-based treatment programs are effective in increasing lumbopelvic muscle thickness and core muscle endurance. Accordingly, we recommend the widespread use of this innovative treatment approach in FMS. Keypoints • FMS patients indicated lower core endurance strengths compared to healthy groups • TG showed greater improvements in muscle thickness and core endurance strength • Telerehabilitation is feasible and effective for managing the complexities of FMS • The telerehabilitation program was superior and more effective than home exercises
- Open Access
- 22 July 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (15) , 5181
Evaluating Secukinumab as Treatment for Axial Spondyloarthritis and Psoriatic Arthritis in Patients with Comorbidities: Multicenter Real-Life Experience
Background: Secukinumab is a fully human monoclonal antibody that targets interleukin (IL)-17A and is used to treat axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA). Treating axSpA and PsA can be challenging in patients with comorbidities. In this multicenter retrospective study, we aimed to evaluate the efficacy and safety of secukinumab treatment in patients with axSpA and PsA who had a history of tuberculosis, multiple sclerosis (MS), or congestive heart failure (CHF). Methods: The study included 44 patients with a diagnosis of axSpA and PsA and a history of tuberculosis, MS, or CHF who received secukinumab treatment at 13 centers in our country. Erythrocyte sedimentation rate, C-reactive protein (CRP), Bath Ankylosing Spondylitis Disease Activity Index, Ankylosing Spondylitis Disease Activity Score CRP, visual analog scale, and Disease Activity Score-28 CRP markers at months 0, 3, and 12 of secukinumab treatment were analyzed. Alongside this, tuberculosis, MS, and CHF were evaluated at follow-up using clinical assessments and imaging methods such as chest radiographs, brain magnetic resonance, and echocardiography. Results: A statistically significant improvement in inflammatory markers and disease activity scores was observed in patients treated with secukinumab. There was no reactivation in patients with a history of tuberculosis. In most MS patients, the disease was stable, while clinical and radiological improvement was observed in one patient. No worsening of CHF stage was observed in patients with a history of CHF. Conclusions: With regular clinical monitoring, secukinumab may be an effective and safe treatment option for axSpA and PsA patients with a history of tuberculosis, MS, or CHF.
- 22 July 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (15) , 5181
Open AccessEvaluating Secukinumab as Treatment for Axial Spondyloarthritis and Psoriatic Arthritis in Patients with Comorbidities: Multicenter Real-Life Experience
Background: Secukinumab is a fully human monoclonal antibody that targets interleukin (IL)-17A and is used to treat axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA). Treating axSpA and PsA can be challenging in patients with comorbidities. In this multicenter retrospective study, we aimed to evaluate the efficacy and safety of secukinumab treatment in patients with axSpA and PsA who had a history of tuberculosis, multiple sclerosis (MS), or congestive heart failure (CHF). Methods: The study included 44 patients with a diagnosis of axSpA and PsA and a history of tuberculosis, MS, or CHF who received secukinumab treatment at 13 centers in our country. Erythrocyte sedimentation rate, C-reactive protein (CRP), Bath Ankylosing Spondylitis Disease Activity Index, Ankylosing Spondylitis Disease Activity Score CRP, visual analog scale, and Disease Activity Score-28 CRP markers at months 0, 3, and 12 of secukinumab treatment were analyzed. Alongside this, tuberculosis, MS, and CHF were evaluated at follow-up using clinical assessments and imaging methods such as chest radiographs, brain magnetic resonance, and echocardiography. Results: A statistically significant improvement in inflammatory markers and disease activity scores was observed in patients treated with secukinumab. There was no reactivation in patients with a history of tuberculosis. In most MS patients, the disease was stable, while clinical and radiological improvement was observed in one patient. No worsening of CHF stage was observed in patients with a history of CHF. Conclusions: With regular clinical monitoring, secukinumab may be an effective and safe treatment option for axSpA and PsA patients with a history of tuberculosis, MS, or CHF.
- Open Access
- 30 June 2025
- Published by AVES YAYINCILIK A.Ş. in Archives of Rheumatology
- Vol. 40 (2) , 230-234
Does Sestrin-1 Mitigate Cardiovascular Risks in Radiographic Axial Spondyloarthritis?
Background/Aims: Radiographic axial spondyloarthritis (r-axSpA) is a chronic inflammatory arthritis associated with increased cardiovascular (CV) risk due to persistent inflammation. Sestrin-1, an antioxidant and anti-inflammatory protein, has been implicated in CV protection. This study investigated relationships between Sestrin-1 levels, CV markers, and echocardiographic findings in r-axSpA patients. Materials and Methods: Controlled study of 48 r-axSpA patients (modified New York criteria) and 48 age- and sex-matched healthy controls. Collected demographic, biochemical, and echocardiographic data. Measured Sestrin-1 by ELISA; assessed carotid intima-media thickness via ultrasound. Statistical analyses evaluated group differences and correlations between Sestrin-1 and inflammatory/CV parameters. Results: r-axSpA patients had significantly lower Sestrin-1 levels than controls (P = .003). Sestrin-1 negatively correlated with CRP (r = –0.42) and ESR (r = –0.38). Echocardiography showed increased CIMT (P < .001), reduced RVSM, and lower TAPSE in r-axSpA patients. No correlation between Sestrin-1 and ASDAS-CRP. Conclusion: r-axSpA patients exhibit reduced Sestrin-1 and subclinical CV changes, suggesting Sestrin-1 may contribute to CV risk in r-axSpA. Further research is needed on Sestrin-1 as a biomarker for CV complications.
- 30 June 2025
- Published by AVES YAYINCILIK A.Ş. in Archives of Rheumatology
- Vol. 40 (2) , 230-234
Open AccessDoes Sestrin-1 Mitigate Cardiovascular Risks in Radiographic Axial Spondyloarthritis?
Background/Aims: Radiographic axial spondyloarthritis (r-axSpA) is a chronic inflammatory arthritis associated with increased cardiovascular (CV) risk due to persistent inflammation. Sestrin-1, an antioxidant and anti-inflammatory protein, has been implicated in CV protection. This study investigated relationships between Sestrin-1 levels, CV markers, and echocardiographic findings in r-axSpA patients. Materials and Methods: Controlled study of 48 r-axSpA patients (modified New York criteria) and 48 age- and sex-matched healthy controls. Collected demographic, biochemical, and echocardiographic data. Measured Sestrin-1 by ELISA; assessed carotid intima-media thickness via ultrasound. Statistical analyses evaluated group differences and correlations between Sestrin-1 and inflammatory/CV parameters. Results: r-axSpA patients had significantly lower Sestrin-1 levels than controls (P = .003). Sestrin-1 negatively correlated with CRP (r = –0.42) and ESR (r = –0.38). Echocardiography showed increased CIMT (P < .001), reduced RVSM, and lower TAPSE in r-axSpA patients. No correlation between Sestrin-1 and ASDAS-CRP. Conclusion: r-axSpA patients exhibit reduced Sestrin-1 and subclinical CV changes, suggesting Sestrin-1 may contribute to CV risk in r-axSpA. Further research is needed on Sestrin-1 as a biomarker for CV complications.
- Open Access
- 21 April 2025
- Published by Ahi Evran Medical Journal, Kirsehir Ahi Evran University in Ahi Evran Medical Journal
- Vol. 9 (1) , 30-36
The Role of Disease Activity as a Determinant of Central Sensitivity and Body Awareness in Fibromyalgia Patients: A Cross-Sectional Study
Purpose: The present study aimed to identify the influence of disease activity on central sensitization (CS) and body awareness in fibromyalgia syndrome (FMS) patients. Materials and Methods: Forty-five patients with FMS (mean age: 45.9 (6.9) years, median disease duration: 3 (2-6) years) were participated this cross-sectional study. Disease activity was assessed using the Fibromyalgia Impact Questionnaire (FIQ) and higher score was considered high disease activity. The Central Sensitization Inventory (CSI) was performed for central sensitivity. Body awareness levels were evaluated with the Body Awareness Questionnaire (BAQ). Visual Analogue Scale (VAS) was used to identify pain severity. Simple linear regression analyses were used to determine which independent variables could explain disease activity. Results: The mean FIQ and BAQ were 53.4 and 90 points, respectively. The median VAS and CSI were 8 cm and 52 point, respectively. The CS is positive in 82.2% of all patients. FIQ was moderately correlated with the VAS score (r=0.445, R2=0.198, p=0.002) and is highly correlated with CSI (r=0.539, R2=0.291, p<0.001). There was no significant correlation between FIQ and BAQ (p=0.791). The results of the simple linear regression analysis presented that VAS explained 19.8% of the the disease activity. FIQ (r=0.445, p=0.002) significantly predicted pain severity. Additionally, The CSI explained 29.1% of the disease activity and FIQ (r=0.539, p<0.001) significantly predicted CS. Conclusion: High disease activity negatively impacts CS and body awareness in FMS patients. Clinicians should consider a multimodal biopsychosocial perspective in addition to routine treatments in the management of patients with high disease activity.
- 21 April 2025
- Published by Ahi Evran Medical Journal, Kirsehir Ahi Evran University in Ahi Evran Medical Journal
- Vol. 9 (1) , 30-36
Open AccessThe Role of Disease Activity as a Determinant of Central Sensitivity and Body Awareness in Fibromyalgia Patients: A Cross-Sectional Study
Purpose: The present study aimed to identify the influence of disease activity on central sensitization (CS) and body awareness in fibromyalgia syndrome (FMS) patients. Materials and Methods: Forty-five patients with FMS (mean age: 45.9 (6.9) years, median disease duration: 3 (2-6) years) were participated this cross-sectional study. Disease activity was assessed using the Fibromyalgia Impact Questionnaire (FIQ) and higher score was considered high disease activity. The Central Sensitization Inventory (CSI) was performed for central sensitivity. Body awareness levels were evaluated with the Body Awareness Questionnaire (BAQ). Visual Analogue Scale (VAS) was used to identify pain severity. Simple linear regression analyses were used to determine which independent variables could explain disease activity. Results: The mean FIQ and BAQ were 53.4 and 90 points, respectively. The median VAS and CSI were 8 cm and 52 point, respectively. The CS is positive in 82.2% of all patients. FIQ was moderately correlated with the VAS score (r=0.445, R2=0.198, p=0.002) and is highly correlated with CSI (r=0.539, R2=0.291, p<0.001). There was no significant correlation between FIQ and BAQ (p=0.791). The results of the simple linear regression analysis presented that VAS explained 19.8% of the the disease activity. FIQ (r=0.445, p=0.002) significantly predicted pain severity. Additionally, The CSI explained 29.1% of the disease activity and FIQ (r=0.539, p<0.001) significantly predicted CS. Conclusion: High disease activity negatively impacts CS and body awareness in FMS patients. Clinicians should consider a multimodal biopsychosocial perspective in addition to routine treatments in the management of patients with high disease activity.
- Open Access
- 21 February 2025
- Published by Springer Nature in Rheumatology International
- Vol. 45 (3) , 1-11
Evaluation of abdominal and lumbar multifidus muscles thickness and relation to endurance, pain, fatigue and functional mobility in patients with Fibromyalgia syndrome: a case-control study
Objective: The aim of present study was to compare abdominal (transversus abdominis (TrA), internal oblique (IO) and external oblique (EO)) and lumbar multifidus muscles (LM) evaluated with ultrasonographic (US) imaging in patients with FM (Fibromyalgia) and asymptomatic individuals and to examine the relationship between these muscle thickness and endurance, pain, fatigue and functional mobility. Methods: Women with FM group (n: 53, age: 45.96 ± 9.96 years), and asymptomatic control group (n: 49, age: 45.12 ± 7.28), were included in this study. Pain severity, disease activity, physical activity level, fatique, thickness of TrA, IO, EO and LM muscles and endurance, and functional mobility were evaluated with the Visual Analogue Scale (VAS), Fibromyalgia Impact Questionnaire (FIQ), International Physical Activity Questionnaire- Short Form (IPAQ-SF), Fatigue Severity Scale (FSS), US imaging, McGill core endurance tests, and physical fitness tests, respectively. FM patients were classified according to the FSS score. Results: The thickness of the IO (right side) (p = 0.013) and LM (both sides) (p < 0.001) muscles, lumbopelvic muscle endurance (all p < 0.001) and physical fitness tests (all p < 0.001) were lower in FM group compared to the asymptomatic group. No statistically significant differences were found in TrA, IO (left side), EO muscles thickness between the two groups (all p > 0.05). LM muscle thickness was significantly correlated with lumbopelvic muscle endurance (all p < 0.05), physical fitness tests (all p < 0.001) and fatique (p = 0.001). Moreover, significant differences in LM muscle thickness (p = 0.007), trunk flexor muscle endurance (p = 0.016), left trunk lateral flexor muscle endurance (p = 0.045) and 30-s chair stand test (p = 0.025) in favor of the low-fatigue group were detected. Conclusion: The thickness of LM muscle, lumbopelvik endurance and functional mobility in FM patients have been affected negatively. These findings should be considered in management of FM.
- 21 February 2025
- Published by Springer Nature in Rheumatology International
- Vol. 45 (3) , 1-11
Open AccessEvaluation of abdominal and lumbar multifidus muscles thickness and relation to endurance, pain, fatigue and functional mobility in patients with Fibromyalgia syndrome: a case-control study
Objective: The aim of present study was to compare abdominal (transversus abdominis (TrA), internal oblique (IO) and external oblique (EO)) and lumbar multifidus muscles (LM) evaluated with ultrasonographic (US) imaging in patients with FM (Fibromyalgia) and asymptomatic individuals and to examine the relationship between these muscle thickness and endurance, pain, fatigue and functional mobility. Methods: Women with FM group (n: 53, age: 45.96 ± 9.96 years), and asymptomatic control group (n: 49, age: 45.12 ± 7.28), were included in this study. Pain severity, disease activity, physical activity level, fatique, thickness of TrA, IO, EO and LM muscles and endurance, and functional mobility were evaluated with the Visual Analogue Scale (VAS), Fibromyalgia Impact Questionnaire (FIQ), International Physical Activity Questionnaire- Short Form (IPAQ-SF), Fatigue Severity Scale (FSS), US imaging, McGill core endurance tests, and physical fitness tests, respectively. FM patients were classified according to the FSS score. Results: The thickness of the IO (right side) (p = 0.013) and LM (both sides) (p < 0.001) muscles, lumbopelvic muscle endurance (all p < 0.001) and physical fitness tests (all p < 0.001) were lower in FM group compared to the asymptomatic group. No statistically significant differences were found in TrA, IO (left side), EO muscles thickness between the two groups (all p > 0.05). LM muscle thickness was significantly correlated with lumbopelvic muscle endurance (all p < 0.05), physical fitness tests (all p < 0.001) and fatique (p = 0.001). Moreover, significant differences in LM muscle thickness (p = 0.007), trunk flexor muscle endurance (p = 0.016), left trunk lateral flexor muscle endurance (p = 0.045) and 30-s chair stand test (p = 0.025) in favor of the low-fatigue group were detected. Conclusion: The thickness of LM muscle, lumbopelvik endurance and functional mobility in FM patients have been affected negatively. These findings should be considered in management of FM.
- Open Access
- 31 December 2024
- Published by AVES YAYINCILIK A.Ş. in Archives of Rheumatology
- Vol. 39 (4) , 652-661
Increased PCSK9 associated with cIMT in AS: A useful marker for subclinical atherosclerosis in patients with ankylosing spondylitis
Objectives: This study aims to investigate the relationship between proprotein convertase subtilisin/ kexin type 9 (PCSK9) levels and subclinical atherosclerosis (SA) in patients with ankylosing spondylitis (AS). Patients and methods: Between January 2022 and March 2022, a total of 56 patients (33 males, 23 females; mean age: 37.8±9.3 years; range, 20 to 60 years) who were under regular follow-up in our clinic and fulfilled the criteria of the Modified New York Diagnostic Criteria for AS and American College of Rheumatology (ACR) for AS were included. Age- and sex-matched 56 healthy volunteers (25 males, 31 females; mean age: 38.4±8.2 years; range, 20 to 60 years) were also recruited as the control group. Demographic, clinical, and laboratory data were recorded. The PCSK9 level and carotid intima-media thickness (cIMT) were evaluated using appropriate methods. Results: The mean serum PCSK9 levels in AS patients (609.3±149.9 vs. 136.3±120.8 ng/mL, p
- 31 December 2024
- Published by AVES YAYINCILIK A.Ş. in Archives of Rheumatology
- Vol. 39 (4) , 652-661
Open AccessIncreased PCSK9 associated with cIMT in AS: A useful marker for subclinical atherosclerosis in patients with ankylosing spondylitis
Objectives: This study aims to investigate the relationship between proprotein convertase subtilisin/ kexin type 9 (PCSK9) levels and subclinical atherosclerosis (SA) in patients with ankylosing spondylitis (AS). Patients and methods: Between January 2022 and March 2022, a total of 56 patients (33 males, 23 females; mean age: 37.8±9.3 years; range, 20 to 60 years) who were under regular follow-up in our clinic and fulfilled the criteria of the Modified New York Diagnostic Criteria for AS and American College of Rheumatology (ACR) for AS were included. Age- and sex-matched 56 healthy volunteers (25 males, 31 females; mean age: 38.4±8.2 years; range, 20 to 60 years) were also recruited as the control group. Demographic, clinical, and laboratory data were recorded. The PCSK9 level and carotid intima-media thickness (cIMT) were evaluated using appropriate methods. Results: The mean serum PCSK9 levels in AS patients (609.3±149.9 vs. 136.3±120.8 ng/mL, p